We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Guidances, Rules On Exploratory INDs
FDA Issues Guidances, Rules On Exploratory INDs
June 7, 2006
The FDA has released a series of guidances and a rules aimed at speeding products to market by streamlining the investigational new drug (IND) application process.